iOrganBio

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.

Parallel Bio

This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

Orgonex

Orgonex develops automated bioreactor systems for organoid cultivation to assist researchers and pharmaceutical companies with large-scale cell expansion and drug development.

Polyphron

Polyphron manufactures donor-diverse human tissues and develops AI simulation models to help biotechnology and pharmaceutical companies test drug candidates and biological predictions.

Stately Bio

This company develops machine learning imaging platforms and stem cell-derived therapies for biopharmaceutical researchers and clinical institutions.

Bullseye Bio

This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.